CIS-India has posted the current IPR chapter of the EU-India FTA. The text shows the positions of Indian and EU negotiators on each provision, and it shows that India is rejecting TRIPS-Plus Enforcement provisions related to border measures for goods in transit, intermediary liability, and more severe standards for damages. India has also noted that it cannot agree to specific copyright provisions in the trade agreement until it completes a domestic copyright reform effort that is currently under debate in Parliament.
In a statement after the release of the text, Médecins Sans Frontières (MSF) noted that the EU still advocates many TRIP-Plus measures that would jeopardize access to medicines in developing countries, and urged India to resist European pressures. MSF purchases 80% of its pharmaceuticals from Indian generic firms. For more, see the MSF Press Release.
QUT Media4th November 2025 The United Kingdom Parliament is considering a bill aimed at making smoking obsolete, which has been
Speaking at the Global Expert Network on Copyright User Rights Symposium on 16 June 2025, Professor Christophe Geiger argues for
On 25 September 2025, Professor Wend Wendland, delivered the 14th Peter Jaszi Distinguished Lecture at American University in Washington D.C..
On September 18, 2025, the Italian Senate definitively approved the country’s first comprehensive framework law on artificial intelligence (AI). The
Por Andrés Izquierdo Durante la segunda semana de agosto, fui invitado a hablar en la Feria Internacional del Libro de
By Andrés Izquierdo AI, Copyright, and the Future of Creativity: Notes from the Panama International Book FairDuring the second week